Ming Hou

1.3k total citations
31 papers, 461 citations indexed

About

Ming Hou is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Ming Hou has authored 31 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 14 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Ming Hou's work include Platelet Disorders and Treatments (8 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Ming Hou is often cited by papers focused on Platelet Disorders and Treatments (8 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Ming Hou collaborates with scholars based in China, Australia and Switzerland. Ming Hou's co-authors include Jun Peng, Daoxin Ma, Maohong Zhang, Mingqiang Hua, Dong-Jun Lin, Xiangyuan Wu, Jiajun Liu, Qu Lin, Renwei Huang and Michele Baccarani and has published in prestigious journals such as Blood, PLoS ONE and Cancer Letters.

In The Last Decade

Ming Hou

30 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ming Hou China	14	216	188	114	93	70	31	461
Antonella Russo Rossi Italy	12	151 0.7×	92 0.5×	129 1.1×	140 1.5×	93 1.3×	23	384
Xuzhang Lu China	14	212 1.0×	150 0.8×	241 2.1×	56 0.6×	119 1.7×	54	477
Xingxin Li China	13	308 1.4×	123 0.7×	230 2.0×	125 1.3×	74 1.1×	49	588
Jarosław Piszcz Poland	14	104 0.5×	95 0.5×	127 1.1×	160 1.7×	74 1.1×	49	454
Maria Niniraki Greece	9	127 0.6×	86 0.5×	52 0.5×	64 0.7×	59 0.8×	12	335
Yi-Cheng Wang United States	12	288 1.3×	276 1.5×	50 0.4×	55 0.6×	90 1.3×	15	517
Panagiota Matsouka Greece	10	97 0.4×	119 0.6×	58 0.5×	61 0.7×	70 1.0×	23	369
Anna Szmigielska‐Kapłon Poland	16	215 1.0×	198 1.1×	103 0.9×	187 2.0×	151 2.2×	55	570
F. Messa Italy	8	453 2.1×	366 1.9×	71 0.6×	208 2.2×	91 1.3×	15	724
Theo D. Kim United States	10	220 1.0×	58 0.3×	193 1.7×	64 0.7×	109 1.6×	13	423

Countries citing papers authored by Ming Hou

Since Specialization

Citations

This map shows the geographic impact of Ming Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Hou more than expected).

Fields of papers citing papers by Ming Hou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Hou. The network helps show where Ming Hou may publish in the future.

Co-authorship network of co-authors of Ming Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Hou. A scholar is included among the top collaborators of Ming Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Hou. Ming Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Chao, et al.. (2025). Bridging clinical knowledge and AI: an interpretable transformer framework for ECG diagnosis. npj Digital Medicine. 9(1). 41–41.

Wei, Zhichen, Linlin Shao, Shuqian Xu, et al.. (2024). Case report: Successful therapy with azacitidine for acute myeloid leukemia with NUP98::RARG resembling acute promyelocytic leukemia. Frontiers in Oncology. 14. 1460557–1460557. 1 indexed citations

Sarocchi, Matteo, Junmin Li, Depei Wu, et al.. (2024). Cardiac effects of deferasirox in transfusion‐dependent patients with myelodysplastic syndromes: TELESTO study. British Journal of Haematology. 204(5). 2049–2056. 3 indexed citations

Liu, Qinqin, Mingqiang Hua, Chen Zhang, et al.. (2021). NLRP3-activated bone marrow dendritic cells play antileukemic roles via IL-1β/Th1/IFN-γ in acute myeloid leukemia. Cancer Letters. 520. 109–120. 22 indexed citations

Li, Xiaoli, Jing Gong, Yafeng Liang, et al.. (2017). Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trial. Journal of Hematology & Oncology. 10(1). 104–104. 50 indexed citations

Li, Guangyao, Li Zhang, Guozhen Liu, et al.. (2016). Marine drug Haishengsu increases chemosensitivity to conventional chemotherapy and improves quality of life in patients with acute leukemia. Biomedicine & Pharmacotherapy. 81. 160–165. 13 indexed citations

Wang, Hong, Mingqiang Hua, Shukang Wang, et al.. (2016). Genetic polymorphisms of IL-18 rs1946518 and IL-1β rs16944 are associated with prognosis and survival of acute myeloid leukemia. Inflammation Research. 66(3). 249–258. 30 indexed citations

Li, Guangyao, et al.. (2016). shRNA-mediated RPS15A silencing inhibits U937 acute myeloid leukemia cell proliferation and enhances apoptosis. Molecular Medicine Reports. 13(5). 4400–4406. 13 indexed citations

Hou, Ming, et al.. (2015). Cementless Revision for Infected Hip Arthroplasty: an 8.6 Years Follow‐up. Orthopaedic Surgery. 7(1). 37–42. 6 indexed citations

10.

Hao, Li, Xiangxin Li, Fanglin Li, et al.. (2015). A case of simultaneous occurrence of acute myeloid leukemia and multiple myeloma. BMC Cancer. 15(1). 724–724. 5 indexed citations

11.

Li, Xiangxin, Hao Li, Fanglin Li, et al.. (2014). Clinical Study on Prospective Efficacy of All‐Trans Acid, Realgar‐Indigo Naturalis Formula Combined with Chemotherapy as Maintenance Treatment of Acute Promyelocytic Leukemia. Evidence-based Complementary and Alternative Medicine. 2014(1). 987560–987560. 9 indexed citations

12.

Yu, Aixi, et al.. (2014). Effects of Sox9 gene therapy on the healing of bone-tendon junction: An experimental study. Indian Journal of Orthopaedics. 48(1). 88–95. 9 indexed citations

13.

Xiao, Li, Qiang Song, Yu Chen, et al.. (2014). Decitabine of Reduced Dosage in Chinese Patients with Myelodysplastic Syndrome: A Retrospective Analysis. PLoS ONE. 9(4). e95473–e95473. 8 indexed citations

14.

Shao, Linlin, Lei Zhang, Yu Hou, et al.. (2012). Th22 Cells as Well as Th17 Cells Expand Differentially in Patients with Early-Stage and Late-Stage Myelodysplastic Syndrome. PLoS ONE. 7(12). e51339–e51339. 37 indexed citations

15.

Wang, Qian, Jian Ji, Lijuan Liu, et al.. (2012). Expression of IL-27, Th1 and Th17 in Patients with Aplastic Anemia. Journal of Clinical Immunology. 33(2). 436–445. 19 indexed citations

16.

Zhou, Wei, Zheng Jiang, Xingang Li, et al.. (2009). EMP3 Overexpression in Primary Breast Carcinomas is not Associated with Epigenetic Aberrations. Journal of Korean Medical Science. 24(1). 97–97. 21 indexed citations

17.

Liu, Jiajun, Renwei Huang, Dong-Jun Lin, et al.. (2006). Antiproliferation effects of oridonin on HPB-ALL cells and its mechanisms of action. American Journal of Hematology. 81(2). 86–94. 20 indexed citations

18.

Liu, Jiajun, Huiling Lü, Renwei Huang, et al.. (2005). Peroxisome proliferator activated receptor-γ ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells. Cancer Chemotherapy and Pharmacology. 56(4). 400–408. 44 indexed citations

19.

Liu, Jiajun, Renwei Huang, Dong-Jun Lin, et al.. (2005). Apoptotic effect of oridonin on NB4 cells and its mechanism. Leukemia & lymphoma. 46(4). 593–597. 13 indexed citations

20.

Peng, Jun, Chuanfang Liu, Yuanyuan Zhu, et al.. (2003). The TNF2 allele is a risk factor to severe aplastic anemia independent of HLA-DR. Human Immunology. 64(9). 896–901. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact